Here-here Jelly, some of the best and brightest were also a bit looney.
I feel infintely more comfortable buying in the low 2's, that's for sure. At this point, we either have a hell of an upside, or we go bankrupt.
We would definitely get bought before we came anywhere near bankruptcy, that's for sure.
<<Hah, thanks Jelly, but I'm thinking we both may just be crazy. You know the old definition of crazy ... doing the same thing over and over again, and expecting a different result each time.>>
"Crazy" and "smart" are not necessarily mutually exclusive traits.
>>Why is it that every thing you say turns out to be something I agree with. You must be a very smart person. ;-)<<
Hah, thanks Jelly, but I'm thinking we both may just be crazy. You know the old definition of crazy ... doing the same thing over and over again, and expecting a different result each time.
That's kind of like what investing in SUPG is like. It's good to know that there's crazy brethren to share in the pain. ;)
I have yet to figure out exactly what SUPG is getting punished for. Has the only catalyst for this company in the past 2 years really only been that Businessweek article? It seems odd that it ran back then, and it's done nothing but go down ever since...
Why is it that every thing you say turns out to be something I agree with. You must be a very smart person. ;-)
<<This stock was last $2 back in 2004, and the question is, is the company in better or worse position today and in 2004?>>
Believe me, I was here in 2004 and this company is in a far better position now than it was then.
1. Now they have $90 million in the bank. Then they had less than $10 million and it was already earmarked.
2. Now they have an income stream that almost covers expenses. Then they were using every trick in the book to generate enough cash to meet expenses.
3. Now they have a very robust pipeline with more than 6 promising compounds and a development platform to boot. Then they had Dacogen and Orathecin.
I'll probably pick up more if we hit the sub-$2.30s, I bought a semi-large block at $2.40, and after holding 2.45-2.55 for so long, looks like we're breaking to the downside once again (note: I'm not a chartist, and personally believe they have little merit other than to support or refute one's opinion).
We shall see. If we hit close to $2, I'd say back up the truck. This stock was last $2 back in 2004, and the question is, is the company in better or worse position today and in 2004? There's your answer as to whether you should get in or out... the only thing that irritates me is that there's no consistency to this stock, we've whipsawed from 2.10 to 2.98 and back to 2.30 on relatively little news.
Hell, we've dropped from $5 to $2 on no news, other than Dacogen sales are growing and keeping pace w/ Vidaza.
This stock is on sale and I agree with Alpha. I have a considerable holding now but tempted to buy more. I am close to 60K at this level. I would have liked to wait until EROTC and if the stock drops buy another 30-40K to average down. Not sure what to do, I didn't think we would see 2.10 again.
Our large institutional holders seem to be holding. Other institutional holders are selling and have sold a ngative net difference of 1 mil shares. Probably don't like the uncertainity, the negative research reports about EROTC and the continued variability in stock price. Besides all this the US is in an economic recession with a weak dollar. Many funds are looking at over seas investments where the economy is growing.
I know the subprime has a lot more writedowns yet to come. ARM's reset interest rates later this year. Interest rates are headed higher and home values are headed lower.
no1 should ever listen to this clown.
Bought my 1st 500 shares at $3.96.
thats a heck of a long way to average down, ror, and a fantastic call. 50% loss isnt so bad, we suppose. we hope selling those calls helped the avg price as well as the ego!
If you actually provided information on anything SUPG that's substantial
Just read free and lover Billy posted messages for the past year. They know supg so well, I would of thought they were the CEOs of the company. They posted many quarterly results that would impress most non-sayers. And there still doing it as supg only .33 away from a 5 year low.